e-learning
resources
Vienna 2003
Monday 29.09.2003
Lung cancer: clinical presentation and prognostic factors
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Oxidant- antioxidant balance in lung cancer: is there any prognostic correlation?
F. Ulger, T. Karayilanoglu, O. Kumbasar, C. Akay, A. Sayal, N. Numanoglu (Ankara, Turkey)
Source:
Annual Congress 2003 - Lung cancer: clinical presentation and prognostic factors
Session:
Lung cancer: clinical presentation and prognostic factors
Session type:
Thematic Poster Session
Number:
1654
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Ulger, T. Karayilanoglu, O. Kumbasar, C. Akay, A. Sayal, N. Numanoglu (Ankara, Turkey). Oxidant- antioxidant balance in lung cancer: is there any prognostic correlation?. Eur Respir J 2003; 22: Suppl. 45, 1654
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Antioxidant and inflammatory status in lung cancer patients: systemic or local correlation?
Source: Eur Respir J 2006; 28: Suppl. 50, 769s
Year: 2006
Small cell lung cancer: prognostic significance and correlation with clinical and laboratory parameters
Source: Eur Respir J 2007; 30: Suppl. 51, 670s
Year: 2007
Impaired oxidant/antioxidant balance and relationships between inflammatory markers and antioxidants in patients with primary lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 86s
Year: 2006
The prognostic value of the albumin-to-fibrinogen ratio in lung cancer patients.
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019
Assessing the relevance of biological prognostic indices in predicting survival in non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Staging of non-small-cell lung cancer with FDG-PET/CT: Is there a correlation of morphologic tumor characteristics and metabolic activity?
Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life
Year: 2012
Lung function in lung cancer patients: correlation with smoking habit or other physiological variables?
Source: Eur Respir J 2006; 28: Suppl. 50, 771s
Year: 2006
The value of adiponectin as an inflammatory marker in lung cancer?
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
The effect of nutritional indicators on prognosis of patients with advanced lung cancer
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019
COX-2 as prognostic factor in lung cancer: systematic review of the literature with meta-analysis
Source: Annual Congress 2005 - Prognostic factors in lung cancer
Year: 2005
Is smoking status a prognostic factor in resected lung cancer?
Source: ISSN=ISSN 1810-6838, ISBN=, page=78
Year: 2006
Is neutrophil/lymphocyte ratio at the time of diagnosis a valuable prognostic factor in non-small cell lung cancer?
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Elevation of circulating endothelial cell levels in lung cancer – a new prognostic and/or predictive marker?
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008
Is gender a prognostic factor in long term survival non-small cell lung cancer?
Source: Eur Respir J 2002; 20: Suppl. 38, 185s
Year: 2002
A practical measurement of thoracic sarcopenia: correlation with clinical parameters and outcomes in advanced lung cancer
Source: ERJ Open Res 2016: 00085-2015
Year: 2016
A meta-analysis assessing the prognostic value of neutrophil to lymphocyte ratio in lung metastasectomy for colorectal cancer
Source: Virtual Congress 2021 – Innovation in thoracic surgery
Year: 2021
PD-L1 is a potential negative prognostic factor for non-small cell lung cancer: A 5-year-follow-up study
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011
Molecular-pathological correlations in lung cancer
Source: International Congress 2016 – PG7 New guidelines for the classification and staging of lung cancer
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept